Successful Osimertinib Rechallenge with Steroid Therapy after Osimertinib-induced Interstitial Lung Disease

A 62-year-old male with lung adenocarcinoma harboring an exon 19 deletion in the Epidermal growth factor receptor (EGFR) was treated with EGFR-tyrosine kinase inhibitors (TKIs) and several cytotoxic agents. After administering a fifth-line chemotherapy regimen, a liver biopsy revealed a diagnosis of...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Intern Med
Main Authors: Kiriu, Tatsunori, Tamura, Daisuke, Tachihara, Motoko, Sekiya, Reina, Hazama, Daisuke, Katsurada, Masahiro, Nakata, Kyosuke, Nagano, Tatsuya, Yamamoto, Masatsugu, Kamiryo, Hiroshi, Kobayashi, Kazuyuki, Nishimura, Yoshihiro
פורמט: Artigo
שפה:Inglês
יצא לאור: The Japanese Society of Internal Medicine 2017
נושאים:
Case Report
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5799064/
https://ncbi.nlm.nih.gov/pubmed/29033419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.8947-17
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים